Prostatis Group’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Hold
932
0.06% 150
2026
Q1
$322K Hold
932
0.08% 135
2025
Q4
$274K Buy
932
+1
+0.1% +$289 0.07% 143
2025
Q3
$284K Buy
931
+6
+0.6% +$1.64K 0.07% 135
2025
Q2
$232K Buy
+925
New +$213K 0.07% 145
2025
Q1
Sell
-961
Closed -$202K 156
2024
Q4
$202K Buy
961
+7
+0.7% +$1.68K 0.06% 152
2024
Q3
$227K Buy
954
+10
+1% +$2.31K 0.07% 125
2024
Q2
$212K Buy
+944
New +$204K 0.07% 139
2024
Q1
Sell
-1,359
Closed -$286K 148
2023
Q4
$286K Sell
1,359
-12
-0.9% -$2.25K 0.12% 107
2023
Q3
$239K Sell
1,371
-253,201
-99% -$46.6M 0.12% 103
2023
Q2
$263K Buy
254,572
+253,258
+19,274% +$48.5M 0.12% 96
2023
Q1
$258K Buy
1,314
+5
+0.4% +$1.02K 0.14% 88
2022
Q4
$273K Buy
+1,309
New +$295K 0.17% 83
2022
Q3
Sell
-875
Closed -$212K 68
2022
Q2
$212K Buy
875
+15
+2% +$3.62K 0.33% 43
2022
Q1
$214K Buy
+860
New +$200K 0.17% 78
2021
Q4
Sell
-953
Closed -$210K 92
2021
Q3
$210K Sell
953
-47
-5% -$10.7K 0.13% 95
2021
Q2
$216K Buy
1,000
+4
+0.4% +$860 0.15% 96
2021
Q1
$202K Buy
+996
New +$187K 0.16% 93

Other funds holding LHX

Prostatis Group's LHX Position: Q2 2026 in Review

Prostatis Group held its L3Harris (LHX) position steady in Q2 2026 at 932 shares worth $271K. The position accounts for 0.06% of the portfolio, ranked #150.

Prostatis Group first reported a position in LHX in Q1 2021 and has held it in 18 quarters since. The position peaked at $322K in Q1 2026. 1,685 funds tracked by Wall St. Rank hold LHX as of Q2 2026.

  • Prostatis Group held 932 shares of L3Harris worth $271K as of Q2 2026.
  • Prostatis Group left its L3Harris share count unchanged in Q2 2026.
  • L3Harris made up 0.06% of Prostatis Group's portfolio in Q2 2026, its #150 holding.
  • Prostatis Group first reported a position in L3Harris in Q1 2021 and has held it in 18 quarters since.
  • Prostatis Group's L3Harris position peaked at $322K in Q1 2026.
  • 1,685 funds tracked by Wall St. Rank held L3Harris as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.